StockData
NXTSNasdaqPharmaceutical PreparationsFiscal year ends December 31

Nexentis Technologies Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$0.64−0.00 (-0.73%)

Close on Oct 19, 2026

Market cap
$522.65K
P/E (TTM)
–
Dividend yield
–

Nexentis Technologies Inc. balance sheet

Ratios

Latest available, balances at Jun 30, 2026

Profitability, FY

Gross margin
–
Operating margin
–
Net margin
–
Return on equity, FY2025
-38.6%

Financial strength

Current ratio
3.72
Debt to equity
–
Debt to assets
–
Cash to current liabilities
272.6%

Valuation

P/E ratio
–
Price to sales
–
Price to book
0.27
Dividend yield
–